metricas
covid
Clínica e Investigación en Arteriosclerosis (English Edition) Most often read
Journal Information

Most often read

7909
Recommendations of the Spanish Arteriosclerosis Society: The diet in cardiovascular prevention - 2024 Update
Emilio Ros, Pablo Pérez-Martínez, Ramón Estruch, José López-Miranda, Cristina Soler Ferrer, Javier Delgado-Lista, Francisco Gómez-Delgado, Rosa Solà, Vicente Pascual
Clin Investig Arterioscler. 2025;37:
7909
Full text access
Open Article
391
Evidence on cardiovascular prevention with icosapent ethyl
Jose Luis Díaz-Díaz
Clin Investig Arterioscler. 2025;37 Supl 1:
391
Full text access
Open Article
292
Icosapent ethyl: From the REDUCE-IT trial to clinical practice
Juan Pedro-Botet
Clin Investig Arterioscler. 2025;37 Supl 1:
292
Full text access
Open Article
145
Efficiency of fixed-dose combinations of statin and ezetimibe in the treatment of hypercholesterolemia
Carlos Guijarro, Angel Diaz, Eva Moreno, Paula Gamonal, Maria Soler, Neus Vidal-Vilar, Maria Rosa Fernandez
Clin Investig Arterioscler. 2025;37:
145
Full text access
Open Article
117
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study
Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Antonio Segura Fragoso, Verónica Fernández-Pascual, Beatriz Sánchez-Sánchez, María Inmaculada Cervera-Pérez, Francisco Javier Alonso-Moreno, ... on behalf of the Investigators of the AGORA study, of the Spanish Society of Primary Care Physicians SEMERGEN Foundation
Clin Investig Arterioscler. 2025;37:
117
113
Analysis of lipoprotein (a) determination in a selection of Spanish Clinical Laboratories. Batary study
Teresa Arrobas Velilla, Salomon Martin Perez, Carla Fernández Prendes, Maria Jose Castro Castro, Silvia Camos Anguila, Antonio Leon Justel
Clin Investig Arterioscler. 2025;37:
113
Full text access
Open Article
104
COPD and cardiovascular risk
Carlos Santiago Díaz, Francisco J. Medrano, N. Muñoz-Rivas, Luis Castilla Guerra, M. Belén Alonso Ortiz
Clin Investig Arterioscler. 2025;37:
104
103
Cardiovascular prevention studies in a population with hypertriglyceridemia
Ovidio Muñiz-Grijalvo
Clin Investig Arterioscler. 2025;37 Supl 1:
103
Full text access
Open Article
95
Treatment of hypertriglyceridemia to reduce cardiovascular risk
Carlos Guijarro Hérraiz
Clin Investig Arterioscler. 2025;37 Supl 1:
95
Full text access
Open Article
93
Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk
José López-Miranda
Clin Investig Arterioscler. 2025;37 Supl 1:
93
Full text access
Open Article
88
Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm
Rafael Almendra-Pegueros, Antonio J. Barros-Membrilla, Elvira Pérez-Marlasca, Josep Julve, José Martinez-González, Cristina Rodriguez, María Galán
Clin Investig Arterioscler. 2025;37:
88
84
Nutritional habits in patients with peripheral arterial disease: Adherence to the Mediterranean diet
Elena Vilalta Doñate, Francisca García Fernández, Salvador Martínez Meléndez, Consuelo Castillo Castillo, Pablo Salas Medina, Isabel Almodóvar Fernández
Clin Investig Arterioscler. 2025;37:
84
80
Efficacy and safety of PCSK9 inhibitors in real life
Antón González-Guerrero, Eugenia Navarrete-Rouco, David Benaiges, Eva Giralt-Steinhauer, Lidia Marcos, Anna Oliveras, Lluis Recasens, Juan Pedro-Botet
Clin Investig Arterioscler. 2025;37:
80
79
The impact of metabolic syndrome on coronary artery severity in patients with acute myocardial infarction: A perspective from a developing country
Hai Phuong Nguyen Tran, Tai Nhat Nguyen, Kha Minh Nguyen, Sang Quang Ly, Sy Van Hoang
Clin Investig Arterioscler. 2025;37:
79
Full text access
Open Article
73
Diabesity and cardiovascular mortality in a prospective population cohort followed for more than 20 years
Julio A. Carbayo-Herencia, Marta Simarro Rueda, Luis Miguel Artigao Ródenas, Juan A. Divisón Garrote, Francisca Molina Escribano, Isabel Ponce García, Antonio Palazón Bru, Pilar Torres Moreno, ... on behalf of the Albacete Vascular Diseases Group (GEVA)
Clin Investig Arterioscler. 2025;37:
73
70
Extracellular vesicles in atherosclerosis: Current and forthcoming impact.
José A. Páramo, Ana Cenarro, Fernando Civeira, Carmen Roncal
Clin Investig Arterioscler. 2025;37:
70
Full text access
Open Article
67
The mechanisms underlying the cardiac effects of modified citrus pectin in obese rats with myocardial ischemia: Role of galectin-3
Sara Jiménez-González, Beatriz Delgado-Valero, Ana Romero-Miranda, Fabian Islas, María Luaces, Bunty Ramchandani, María Cuesta-Corral, Alejandro Montoro-Garrido, ... Victoria Cachofeiro
Clin Investig Arterioscler. 2025;37:
67
Full text access
Open Article
66
The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients
Kung-Hung Lin, Nuria Amigo, Pablo Ortiz, Cristina Alonso, Alexander V. Smolensky, Deven Parmar, Naga P. Chalasani, Samer Gawrieh
Clin Investig Arterioscler. 2025;37:
66
Full text access
Open Article
64
Elevated plasma levels of TNF-R1 predict the development of acute ischemic events in coronary patients with diabetes
Sebastián Mas-Fontao, Nieves Tarín, Carmen Cristóbal, Manuel Soto-Catalán, Ana Pello, Alvaro Aceña, Jairo Lumpuy-Castillo, Carmen Garces, ... José Tuñón
Clin Investig Arterioscler. 2025;37:
64
Article options
Tools